# A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa

> **NCT03855995** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 77953 (actual)

## Conditions studied

- Malaria
- Malaria Vaccines

## Interventions

- **PROCEDURE:** Whole blood sample

## Key facts

- **NCT ID:** NCT03855995
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-21
- **Primary completion:** 2025-08-07
- **Final completion:** 2025-08-07
- **Target enrollment:** 77953 (ACTUAL)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03855995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03855995, "A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03855995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*